Teva is a global biopharmaceutical company with a large generics business and a continuing focus on innovative medicines. Its corporate website describes core innovation priorities in therapeutic areas such as neuroscience and immunology, alongside generics and biosimilars. The Canadian business is based in Toronto and supports access to a broad portfolio of established and specialty medicines.